Tech Company Financing Transactions

Redesign Science Funding Round

Redesign Science closed a $2 million Seed funding round on 10/16/2019. Backers included Notation Capital, private investors and Morningside Group.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Healthcare IT

Mailing Address

180 Varick St.
New York, NY 10014
USA

Phone

Undisclosed

Website

www.redesignscience.com

Email Address

Not Recorded

Overview

Redesign Science develops and applies a molecular dynamics-driven platform for in silico drug discovery against emerging drug target classes. We work in partnership with Biotech and Pharma to co-develop novel small molecule therapeutics.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

David Rooklin

        

Chief Technical Officer

Haotian Li

        

Browse more venture capital transactions:

Prev: 10/16/2019: Cyteir Therapeutics venture capital transaction
Next: 10/16/2019: Azitra venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to record every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary